PLIANT THERAPEUTICS INC (PLRX) Institutional Ownership Changes & 13F Activity
PLIANT THERAPEUTICS INC (PLRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Adar1 Capital Management, Llc, Two Sigma Investments, Lp, Redmile Group, Llc, Millennium Management Llc, and Citadel Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Cornerstone Financial Management Llc | Sell | -319 | -100.0% | 0 | $0.00 | Q1 2026 | Aug 28, 2026 |
| Torno Capital, Llc | Buy | +30,000 | +9.4% | 350,000 | $441.00K | Q1 2026 | Aug 17, 2026 |
| Adar1 Capital Management, Llc | Buy | +2,511,307 | +3402.0% | 2,585,126 | $3.26M | Q1 2026 | May 18, 2026 |
| Bank Of America Corp | Sell | -359,069 | -50.4% | 352,708 | $444.41K | Q1 2026 | May 18, 2026 |
| Two Sigma Investments, Lp | Buy | +1,299,845 | +136.4% | 2,253,138 | $2.84M | Q1 2026 | May 15, 2026 |
| Redmile Group, Llc | Sell | -844,102 | -52.2% | 772,126 | $972.88K | Q1 2026 | May 15, 2026 |
| Millennium Management Llc | Buy | +771,687 | +188.8% | 1,180,518 | $1.49M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Buy | +643,267 | +24.9% | 3,226,599 | $4.07M | Q1 2026 | May 15, 2026 |
| Dafna Capital Management Llc | Buy | +487,000 | — | 487,000 | $613.62K | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Sell | -359,361 | -17.7% | 1,666,830 | $2.10M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +319,971 | +115.6% | 596,837 | $752.01K | Q1 2026 | May 15, 2026 |
| Bridgeway Capital Management, Llc | Buy | +232,100 | +72.2% | 553,630 | $697.57K | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Sell | -175,422 | -29.6% | 417,274 | $526.15K | Q1 2026 | May 15, 2026 |
| Jacobs Levy Equity Management, Inc | Buy | +161,605 | +29.0% | 718,543 | $905.36K | Q1 2026 | May 15, 2026 |
| Prosight Management, Lp | Buy | +111,856 | +7.2% | 1,667,600 | $2.10M | Q1 2026 | May 15, 2026 |
| Verdad Advisers, Lp | Buy | +98,320 | — | 98,320 | $123.88K | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Sell | -84,155 | -7.8% | 995,973 | $1.25M | Q1 2026 | May 15, 2026 |
| Squarepoint Ops Llc | Buy | +64,197 | +64.8% | 163,215 | $205.65K | Q1 2026 | May 15, 2026 |
| Eversept Partners, Lp | Buy | +49,402 | +5.9% | 891,425 | $1.12M | Q1 2026 | May 15, 2026 |
| Quadrature Capital Ltd | Sell | -46,910 | -47.9% | 50,981 | $64.24K | Q1 2026 | May 15, 2026 |
| Xtx Topco Ltd | Sell | -44,178 | -8.1% | 500,838 | $631.06K | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -43,223 | -7.9% | 505,739 | $637.23K | Q1 2026 | May 15, 2026 |
| Nano Cap New Millennium Growth Fund L P | Buy | +40,000 | +17.0% | 275,000 | $346.50K | Q1 2026 | May 15, 2026 |
| Susquehanna International Group, Llp | Buy | +18,755 | +54.8% | 52,956 | $66.72K | Q1 2026 | May 15, 2026 |
| Barclays Plc | Sell | -10,550 | -99.7% | 34 | $43.00 | Q1 2026 | May 15, 2026 |
| Qube Research & Technologies Ltd | Sell | -4,459 | -28.9% | 10,966 | $13.82K | Q1 2026 | May 15, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +3,315 | — | 3,315 | $4.18K | Q1 2026 | May 15, 2026 |
| Fmr Llc | Sell | -1,410 | -72.9% | 524 | $660.00 | Q1 2026 | May 15, 2026 |
| Point72 Asset Management, L.P. | Buy | +517 | +1.1% | 47,054 | $59.29K | Q1 2026 | May 15, 2026 |
| Harbour Investments, Inc. | Buy | +488 | — | 488 | $615.00 | Q1 2026 | May 15, 2026 |
Frequently asked questions about PLRX activity
Which institutional owners are buying PLRX?
Institutional owners buying PLRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in PLRX activity?
"Buy" means an investor increased their reported position in PLRX compared to the prior reporting period. This reflects growing exposure to PLIANT THERAPEUTICS INC (PLRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in PLRX increasing?
Institutional interest in PLRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related PLRX Institutional Insights
- PLRX Overview
- PLRX 13F Institutional Holders
- PLRX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- PLRX Insider Trading & SEC Form 4 Activity
- PLRX Articles
- Top Institutional Investor Stock Rankings